Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-091290
Filing Date
2022-08-15
Accepted
2022-08-15 16:59:57
Documents
1
Group Members
PETER KOLCHINSKYRAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2223217-1_sc13ga.htm SC 13G/A 61172
  Complete submission text file 0001104659-22-091290.txt   62789
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92424 | Film No.: 221166469
SIC: 2834 Pharmaceutical Preparations